Nucl Med Mol Imaging.
2017 Jun;51(2):190-192. 10.1007/s13139-015-0384-7.
F-18 FDG PET Findings for Vogt-Koyanagi-Harada Disease
- Affiliations
-
- 1Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Korea. iryoo@catholic.ac.kr
- KMID: 2446902
- DOI: http://doi.org/10.1007/s13139-015-0384-7
Abstract
- Vogt-Koyanagi-Harada disease is a rare multisystemic granulomatous autoimmune disorder affecting pigmented tissues such as the choroid, meninges, inner ear, and the skin. Neurologic symptoms are usually mild. Clinical manifestations include generalized muscle weakness, headache, meningismus, vertigo, decreased visual acuity, hearing loss and mental changes ranging from mild confusion to psychosis, hemiparesis, dysarthria, and aphasia. Seizures are very rare. We describe a case of ¹â¸F-fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET) and software-fused PET-magnetic resonance imaging (MRI) in Vogt-Koyanagi-Harada disease with seizure.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Vogt-Koyanagi-Harada Syndrome Associated with Psoriasis Vulgaris
- A Case of Vogt-Koyanagi-Harada's Syndrome
- A Case of Vogt-Koyanagi-Harada syndrome presenting initially with recurrent vertigo
- A Case of Vogt-Koyanagi-Harada Syndrome
- Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization in Vogt-Koyanagi-Harada Syndrome
